Value-based pricing of drugs with multiple indications or in combinations - lessons from Europe

Affiliations

• ¹ Institute of Law, University of Zurich, Zurich, Switzerland. kerstinnoelle.vokinger@usz.ch.
• ² Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. kerstinnoelle.vokinger@usz.ch.
• ³ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.